AzTrials
AzTrials

InfertilityNCT03931187

Double ABCX Theory Based Cognitive Psychotherapy Combined Progressive Muscle Relaxation Intervention on Women Undergoing IVF-ET

A study testing Cognitive progressive muscular relaxation therapy in people with Infertility, run by Central South University at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The in vitro fertilization and embryo transfer(IVF-ET) is a therapy to help the infertile couples. The mental health status of couple under IVF-ET, commonly seen in depression and anxiety, is found to be closely related to the success of IVF-ET. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Infertility
What is being tested?
Cognitive progressive muscular relaxation therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
67 participants
Where
1 siteChina
Study dates
1 Dec 2018to 1 Jul 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The couple who are eligible for in vitro fertilization-embryo transfer (IVF-ET) treatment;
  • Junior high school and above;
  • voluntarily accepted for investigation and signed informed consent.

Who cannot join

  • Suffering from physical diseases such as severe heart, liver and kidney, and mental disorders;
  • Experiencing major traumatic events in the past 2 years.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Infertility Reproductive Center, Second Xiangya Hospital, Central South University

    Changsha, Hunan, 410013

Other trials in China

About this study

Official title: Double ABCX Theory Based Cognitive Psychotherapy Combined Progressive Muscle Relaxation Intervention on Women Undergoing In Vitro Fertilization-Embryo Transfer Treatment

The in vitro fertilization and embryo transfer(IVF-ET) is a therapy to help the infertile couples. The mental health status of couple under IVF-ET, commonly seen in depression and anxiety, is found to be closely related to the success of IVF-ET. This study aims to develop a intervention program combing cognitive psychotherapy and progressive muscle relaxation to ease the negative emotion and promote the success rate among couples undergoing IVF-ET.

Conditions
Infertility
Being tested
Cognitive progressive muscular relaxation therapy
Keywords
cognitive psychotherapy, progressive muscular relaxation, in vitro fertilization and embryo transfer(IVF-ET), Couples Therapy
Medical subject headings
Infertility

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive progressive muscular relaxation therapyBehavioural

    This therapy combines cognitive psychotherapy and progressive muscular relaxation, intervened 6 times with 1-1.5 hour each time. The whole therapy will last round 28-30 days during IVF-ET.

Study groups in NCT03931187
Study groupRoleWhat they receive
Women intervention armExperimentalIntervention will be applied to the women within the couple.
Receives: Behavioral: Cognitive progressive muscular relaxation therapy
Couple intervention armExperimentalIntervention will be applied to the couple, both men and women.
Receives: Behavioral: Cognitive progressive muscular relaxation therapy
Control armNo interventionThe couple will receive the normal nursing care.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of depression score

    The Self-reported Depression Scale (SDS)will be used to assess the score of depression.The total score of SDS ranges from 0-80, with 40 as the cutoff. The higher the total score, the more depressive.

    Measured: The investigators will measure the socre of depression at baseline and immediately after intervention ( the duration of intervention is around 1 month).

  2. Change of anxiety score

    The Self-reported Anxiety Scale (SAS) will be used to assess the score of anxiety.The total score of SAS ranges from 0-80, with 30 as the cutoff. The higher the total score, the more anxious.

    Measured: The investigators will measure the socre of anxiety at baseline and immediately after intervention ( the duration of intervention is around 1 month).

Secondary outcomes (3)
  1. Change of Blood Cortisol

    This is a kind of hormone closely related to stress, and the investigators will measure the level of Blood Cortisol by Blood test.

    Measured: The investigators will measure the socre of Blood Cortisol at baseline and immediately after intervention ( the duration of intervention is around 1 month).

  2. Change of sleeping quality

    The physical condition closely related to stress. The investigators will use Self-Rating Scale of Sleep to measure the sleeping quality of the participants. The total sore ranges from 5 to 50, with higher score reflects better sleep quality.

    Measured: The investigators will measure the socre of sleeping quality at baseline and immediately after intervention ( the duration of intervention is around 1 month).

  3. Successful conception rate (%)

    The investigators will count the successful conception rate at each arms.

    Measured: The doctor will test whether it is successfully conceived 4 weeks after the embryo is implanted. The last intervention is on the day of embryo implantation. The investigators will count this 4 weeks after completion of intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Apr 2019
  2. Study start1 Dec 2018
  3. Primary completion1 May 2019
  4. Study completion1 Jul 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
67 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03931187
Sponsor's protocol ID
Intervention on IVF-ET
Status last verified
Nov 2021
First submitted
23 Apr 2019
Last updated
14 Dec 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The participants are not willing to share the data.

Publications

  • Wang A, Zhang W, Li H, Guo Y, Yu NX, Zhang J. An 8-week community-based resilience group intervention for Chinese parents who lost their only child: A two-armed pragmatic waitlist-control trial. Psychol Trauma. 2025 Jan;17(1):225-234. doi: 10.1037/tra0001670. Epub 2024 Apr 22.

    PubMed 38647487
  • Chen D, Wang A, Zhang W, Guo Y, Yao S, Chen X, Zhang J. Effectiveness of double ABCX-based psychotherapy for psychological distress among women undergoing in vitro fertilization-embryo transfer: a three-arm randomized controlled trial. J Psychosom Obstet Gynaecol. 2023 Dec;44(1):2278015. doi: 10.1080/0167482X.2023.2278015. Epub 2023 Dec 6.

    PubMed 38056467

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive progressive muscular relaxation therapy in people with Infertility, run by Central South University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Dec 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of depression score (time frame: The investigators will measure the socre of depression at baseline and immediately after intervention ( the duration of intervention is around 1 month).). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03931187, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Dec 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in